Survey of Stereotactic Body Radiation Therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 2, 2009, Pages 343-347

  Nagata, Yasushi ^a   Hiraoka, Masahiro ^b   Mizowaki, Takashi ^b   Narita, Yuichiro ^b   Matsuo, Yukinori ^b   Norihisa, Yoshiki ^b   Onishi, Hiroshi ^c   Shirato, Hiroki ^d  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Liver cancer; Lung cancer; SBRT; Stereotactic radiotherapy; Survey

Indexed keywords

AVERAGE NUMBERS; CURRENT STATUS; ESOPHAGITIS; EXTERNAL BEAM RADIOTHERAPY; LIVER CANCER; LIVER CANCERS; LUNG CANCER; LUNG TUMOR; METASTATIC LUNG CANCER; PRIMARY LIVER CANCERS; RADIATION ONCOLOGISTS; RADIATION PNEUMONITIS; SBRT; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC BODY RADIOTHERAPY; STEREOTACTIC RADIOTHERAPY; TREATMENT PLANNING;

FLOW PATTERNS; LIVER; PERSONNEL; QUALITY ASSURANCE; QUALITY CONTROL; RADIOTHERAPY; SOCIETIES AND INSTITUTIONS; SURVEYS; TOTAL QUALITY MANAGEMENT;

THREE DIMENSIONAL;

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGITIS; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE QUALITY; HEMOPTYSIS; HUMAN; JAPAN; LIVER CANCER; LUNG CANCER; MEDICAL SOCIETY; MEDICAL SPECIALIST; METASTASIS; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT DURATION; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; HEALTH CARE SURVEYS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; JAPAN; LIVER NEOPLASMS; LUNG NEOPLASMS; QUESTIONNAIRES; RADIATION ONCOLOGY; RADIOSURGERY; RADIOTHERAPY, CONFORMAL; RESPIRATION; TIME FACTORS;

EID: 69549126284     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.087     Document Type: Article

References (31)

1. Lax I., Blomgren H., Näslund I., et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33 (1994) 677-683
2. Blomgren H., Lax I., Näslund I., et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol 34 (1995) 861-870
3. Lax I., Blomgren H., Larson D., et al. Extracranial stereotactic radiosurgery of localized targets. J Radiosurgery 1 (1998) 135-148
4. Blomgren H., Lax I., Göranson H., et al. Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurgery 1 (1998) 63-74
5. Uematsu M., Shioda A., Tahara K., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer 82 (1998) 1062-1070
6. Wulf J., Haedinger U., Oppitz U., et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655
7. Herfarth K.K., Debus J., Lohr F., et al. Stereotactic single dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 19 (2001) 164-170
8. Uematsu M., Shioda M., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
9. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
10. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
11. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 (2003) 126-135
12. Lee S., Choi E., Park H., et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40 (2003) 309-315
13. Wulf J., Haedinger U., Oppitz U., et al. Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: A non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 (2004) 186-196
14. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma. Cancer 101 (2004) 1623-1631
15. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
16. Wulf J., Baier K., Mueller G., et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
17. Zimmermann F., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48 (2005) 107-114
18. McGarry R., Papiez L., Williams M., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: Phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
19. Schefter T., Kavanagh B., Timmerman R., et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62 (2005) 1371-1378
20. Takayama K., Nagata Y., Negoro Y., et al. Treatment planning of stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1565-1571
21. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45 (2006) 787-795
22. Fritz P., Kraus H.J., and Muhlnickel W. Stereotactic single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 1 (2006) 30
23. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
24. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
25. Hara R., Itami J., Kondo T., et al. Clinical outcomes of single-fraction radiation therapy for lung tumors. Cancer 1006 (2006) 1347-1352
26. Kavanagh B.D., McGarry R., and Timmerman R.D. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 16 (2006) 77-84
27. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
28. Wulf J., Guckenberger M., Haedinger U., et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45 (2006) 838-847
29. Kavanagh B., Schefter T., Cardenes H., et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45 (2006) 848-855
30. Dawson L., Eccles C., and Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45 (2006) 856-864
31. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839